Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 23 Apr 2026 for Allogene Therapeutics, Inc., €19k. Read the official filing
Filing timeline
BuySaleAnnie Yoshiyama
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Annie Yoshiyama: trading record in brief
Annie Yoshiyama is a declared insider of Allogene Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 24 January 2025 to 21 April 2026, the count stands at 4 filings.
Every open-market trade on record is a sale: 3 sales worth €37k. Besides market trades, the filings include 1 share grant. 2026 to date brings no purchases and 2 sales.
The record was last updated on 23 April 2026 with an open-market sale (€19k) in Allogene Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Annie Yoshiyama
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
9,586 shares@ US$2.310.0030% mcap75.7% of flowCommon StockSEC:0001835208-26-000003:0
4,167 shares@ US$1.7224.3% of flowCommon StockSEC:0001737287-26-000005:0
9,601 shares@ US$1.41100.0% of flowCommon StockSEC:0001835208-25-000007:0
36,232 shares0Common StockSEC:0001737287-25-000007:0
4 of 4 declarations
